Poland· PL-100532235
Spinraza
A nusinersen product containing nusinersenum, registered in Poland by Biogen Netherlands B.V.. The same ATC class is registered in 13 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Nusinersen is registered in 13 of 19 countries.
Countries holding a registration under ATC M09AX07 (nusinersen), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 8 of them publish a price we can compare per daily dose
Nusinersen · ATC M09AX07
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of nusinersen costs, country by country.
Normalised to the WHO defined daily dose (0.1 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Nusinersen · price per daily dose (0.1 mg)
USD · FX 28 Sept 2026
- CH Switzerland$531.69
The record
At a glance
URPL (Poland)- Active substance
- Nusinersenum
- Manufacturer
- Biogen Netherlands B.V.
- Country
- Poland (PL)
- ATC code
- M09AX07
- ATC class
- Nusinersen
- Defined daily dose
- 0.1 mg, P
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05713219599702
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Nusinersen in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainSPINRAZA 50 MG SOLUCION INYECTABLEBiogen Netherlands B.V.
- FinlandSpinrazaBiogen Netherlands B.V.
- IcelandSpinrazaBiogen Netherlands B.V.
- NetherlandsSpinraza 50 mg oplossing voor injectieBiogen Netherlands B.V.
- SwedenSpinraza 50 mg Injektionsvätska, lösningBiogen Netherlands B.V.
- SwitzerlandSpinraza 12mg/5ml, Injektionslösung zur intrathekalen InjektionBiogen Switzerland AG
- United StatesSpinrazaBiogen Inc.
- IrelandSpinraza 12 mg solution for injectionBiogen Netherlands B.V.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Spinraza
- Liechtenstein · Spinraza
- Norway · Spinraza
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/51246630-a8dd-45e0-b1f1-b3f2c8dd1481 GET /v1/drugs/51246630-a8dd-45e0-b1f1-b3f2c8dd1481?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór do wstrzykiwań",
"source": "urpl",
"strength": "50 mg",
"packaging": "05713219599702 ¦ Rpz ¦ EU/1/17/1188/003 ¦ 165595\n1 fiol. 5 ml",
"substance": "Nusinersenum natricum 50 mg",
"common_name": "Nusinersenum",
"pl_product_id": "100532235",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about nusinersen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.